A detailed history of Nebula Research & Development LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 10,018 shares of BSX stock, worth $960,726. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,018
Previous 41,544 75.89%
Holding current value
$960,726
Previous $4.19 Billion 74.32%
% of portfolio
0.09%
Previous 0.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$89.7 - $107.41 $2.83 Million - $3.39 Million
-31,526 Reduced 75.89%
10,018 $1.08 Billion
Q1 2025

May 15, 2025

BUY
$89.38 - $106.18 $2.76 Million - $3.28 Million
30,848 Added 288.41%
41,544 $4.19 Billion
Q4 2024

Feb 14, 2025

BUY
$83.62 - $91.5 $180,702 - $197,731
2,161 Added 25.32%
10,696 $955 Million
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $622,713 - $716,940
8,535 New
8,535 $715 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $137B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.